Needham Initiates Coverage On ATAI Life Sciences with Buy Rating, Announces Price Target of $12

Benzinga · 10/13/2025 10:08
Needham analyst Ami Fadia initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Target of $12.